Praleene Sivapalan
Overview
Explore the profile of Praleene Sivapalan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kjaer M, Bruun C, Granholm A, Moller M, Rasmussen B, Mortensen C, et al.
Crit Care Med
. 2025 Mar;
53(3):e575-e589.
PMID: 40036020
Objectives: Randomized clinical trials informing clinical practice (e.g., like large, pragmatic, and late-phase trials) should ideally mostly use harmonized outcomes that are important to patients, family members, clinicians, and researchers....
2.
Bharwani A, Dionne J, Perez M, Englesakis M, Meyhoff T, Sivapalan P, et al.
J Crit Care
. 2025 Mar;
87:155045.
PMID: 40023080
Background: Intravenous fluid resuscitation forms a crucial part of the sepsis bundle. However, the perception is that patients with comorbidities such as congestive heart failure, chronic kidney disease, and cirrhosis...
3.
Ellekjaer K, Sivapalan P, Myatra S, Gronningsaeter L, Hastbacka J, Young P, et al.
Acta Anaesthesiol Scand
. 2024 Dec;
69(1):e14553.
PMID: 39627945
Background: Clinical practice guidelines recommend use of buffered crystalloid solutions in critically ill patients but do not distinguish between solutions based on different buffering anions, that is, acetate- versus lactate-buffered...
4.
Sivapalan P, Ellekjaer K, Perner A, Moller M, Granholm A, Gronningsaeter L, et al.
Acta Anaesthesiol Scand
. 2024 Sep;
68(9):1234-1243.
PMID: 39302760
Introduction: Use of albumin is suggested for some patients with shock, but preferences for its use may vary among intensive care unit (ICU) physicians. Methods: We conducted an international online...
5.
Ahlstedt C, Sivapalan P, Rooyackers O, Perner A, Grip J
Intensive Care Med
. 2024 Jul;
50(9):1547-1548.
PMID: 39073579
No abstract available.
6.
Ahlstedt C, Sivapalan P, Kriz M, Jacobson G, Meyhoff T, Kaas-Hansen B, et al.
Intensive Care Med
. 2024 Apr;
50(5):678-686.
PMID: 38598125
Purpose: The aim of this study was to examine the effects of intravenous (IV) fluid restriction on time to resolution of hyperlactatemia in septic shock. Hyperlactatemia in sepsis is associated...
7.
Sivapalan P, Kaas-Hansen B, Meyhoff T, Hjortrup P, Kjaer M, Laake J, et al.
Acta Anaesthesiol Scand
. 2024 Apr;
68(7):975-982.
PMID: 38576165
Background: Variation in usual practice in fluid trials assessing lower versus higher volumes may affect overall comparisons. To address this, we will evaluate the effects of heterogeneity in treatment intensity...
8.
9.
Meyhoff T, Granholm A, Hjortrup P, Sivapalan P, Lange T, Laake J, et al.
Acta Anaesthesiol Scand
. 2023 Nov;
68(3):372-384.
PMID: 37975538
Background: Albumin administration is suggested in patients with sepsis and septic shock who have received large volumes of crystalloids. Given lack of firm evidence, clinical practice variation may exist. To...
10.
Sivapalan P, Meyhoff T, Hjortrup P, Lange T, Kaas-Hansen B, Kjaer M, et al.
Acta Anaesthesiol Scand
. 2023 Oct;
68(2):236-246.
PMID: 37869991
Background: The CLASSIC trial assessed the effects of restrictive versus standard intravenous (IV) fluid therapy in adult intensive care unit (ICU) patients with septic shock. This pre-planned study provides a...